Eisai
4523.T
#2254
Rank
ยฃ6.41 B
Marketcap
ยฃ22.74
Share price
1.82%
Change (1 day)
-13.42%
Change (1 year)
Eisai is a Japanese pharmaceutical company that is engaged in the R&D of drugs for the treatment of dementia and Alzheimer.

EPS for Eisai (4523.T)

EPS in 2025 (TTM): ยฃ0.67

According to Eisai's latest financial reports the company's current EPS (TTM) is ยฃ0.64. In 2026 the company made an earnings per share (EPS) of ยฃ0.64 a decrease over its 2025 EPS that were of ยฃ0.81.

EPS history for Eisai from 2000 to 2025

Annual EPS

Year EPS Change
2026ยฃ0.64-21.04%
2025ยฃ0.8111.85%
2024ยฃ0.72-32.63%
2023ยฃ1.075.52%
2022ยฃ1.02-74.01%
2021ยฃ3.91-66.58%
2020ยฃ11.7198.24%
2019ยฃ5.9117.01%
2018ยฃ5.0537.78%
2017ยฃ3.66-27.62%
2016ยฃ5.0635.33%
2015ยฃ3.74-2.82%
2014ยฃ3.85-27.66%
2013ยฃ5.32-27.49%
2012ยฃ7.34-12.67%
2011ยฃ8.4088.08%
2010ยฃ4.47-11.06%
2009ยฃ5.02-390.15%
2008-ยฃ1.73-127.78%
2007ยฃ6.23347.11%
2006ยฃ1.394.38%
2005ยฃ1.347.4%
2004ยฃ1.2443.03%
2003ยฃ0.8725.09%
2002ยฃ0.7052.67%
2001ยฃ0.4669.76%
2000ยฃ0.27